Addex Therapeutics Ltd (ADXN) — Cash Flow Quality Index
Addex Therapeutics Ltd (ADXN) has a Cash Flow Quality Index of -0.21x as of June 2024. Operating cash flow of $-2.76 Million is below net income of $12.88 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Addex Therapeutics Ltd (ADXN) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Addex Therapeutics Ltd Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Addex Therapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ADXN tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Addex Therapeutics Ltd (2024–2024)
Year-by-year earnings quality comparison for Addex Therapeutics Ltd. For live market cap and the full company financial profile, see ADXN stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.76x | $-5.37 Million | $7.06 Million | — |